Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Catalent Inc (NY: CTLT )

55.47 +0.10 (+0.18%)
Streaming Delayed Price Updated: 10:52 AM EDT, May 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Catalent Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Barron's Weekend Stock Picks: Globalstar Satellites, Catalent And Dell's Delightful Destiny
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
Why Catalent Stock Zoomed 12% Higher This Week
A strong earnings report and a clutch of analyst price target hikes will do that. 
Via The Motley Fool
15 Analysts Have This to Say About Catalent
Via Benzinga
Catalent's Activist Board Presence To Boost Operational Recovery, Analyst Says
Tuesday, Catalent Inc (NYSE: CTLT) reported Q4 adjusted EPS of $0.09, missing the consensus of $0.10, with sales of $1.07 billion, down 17% Y/Y, slightly above the  
Via Benzinga
RBC Capital Maintains Outperform Rating for Catalent: Here's What You Need To Know
Via Benzinga
Why Catalent Stock Surged Nearly 5% Higher Today
Fourth-quarter performance that wasn't too disappointing, plus a settlement with an activist investor, brought some bulls back to the company's shares. 
Via The Motley Fool
Catalent Earnings Preview
Via Benzinga
What 19 Analyst Ratings Have To Say About Catalent
Via Benzinga
Analyst Ratings for Catalent
Via Benzinga
Workhorse Fails to Get Enough Votes to Increase WKHS Stock Count
Workhorse (WKHS) stock is on the move Tuesday after the company failed to get shareholder approval to increase its share count. 
Via InvestorPlace
Can a New CFO Save Canoo (GOEV) Stock?
Canoo (GOEV) stock is getting a boost on Tuesday as investors react to the company naming its new Chief Financial Officer. 
Via InvestorPlace
ORCL Stock Alert: Can AI Hype Really Boost Oracle 20%?
Oracle (ORCL) stock is in the news Tuesday as UBS analyst Karl Keirstead makes a bull case for the information technology company's shares. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
China's Response To Shield Economy From Real Estate Storm, Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle, Google Collaborates With Nvidia In AI Expansion: Today's Top Stories
Bloomberg China Takes Drastic Measures To Shield Economy From Real Estate Storm 
Via Benzinga
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Economy
Catalent (CTLT) Stock Gains on Elliott Deal
Catalent (CTLT) stock is getting a boost on Tuesday after the company reached an agreement with Elliott Investment Management. 
Via InvestorPlace
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.  
Via Benzinga
Exposures COVID-19
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its  
Via Benzinga
Why Novo Nordisk Stock Was Racing Higher on Wednesday
When you have a hot item on the market, it's wise to ramp up production. 
Via The Motley Fool
One Is Not Enough For Famed Weight Loss Drug: Novo Nordisk Taps Thermo Fisher To Ramp Up Wegovy Production
Novo Nordisk A/S (NYSE: NVO) has reportedly enlisted the services of Thermo Fisher Scientific Inc (NYSE: TMO) as its second contract manufacturer for its highly sought-after  
Via Benzinga
Why Is Regeneron Pharmaceuticals Moving Higher Today?
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) earned second-quarter adjusted EPS of $10.24, up 5% Y/Y, beating the $9.92 Stre 
Via Benzinga
Novo Nordisk's Wegovy Supply Delays: FDA Uncovers Catalent Factory Lapses Violating Safety Regulations
The production facility that fills the self-injection pens for the rapidly-growing weight-loss medication Wegovy from Novo Nordisk A/S (NYSE: NVO) has been found to have persistently violated U.S. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 20, 2023
Via Benzinga
Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer: Today's Top Stories
Benzinga Tesla Recalls More Than 17,000 EVs Over Camera, Seat Belt Issues 
Via Benzinga
NVDA Stock Alert; Wolfe Research Just Gave Nvidia a Big Vote of Confidence
Nvidia (NVDA) stock is in the news Thursday after the tech company's shares got new coverage from Wolfe Research analysts. 
Via InvestorPlace
CTLT Stock Alert: What to Know as Elliott Takes a Stake in Catalent
Catalent (CTLT) stock is on the move Thursday as investors react to activist investor Elliott Investment taking a stake in the company. 
Via InvestorPlace
Proxy Truces On The Rise At Catalent: Elliott Builds Significant Stake, Calls For Board Shake-Up
Elliott Investment Management, an activist shareholder, has reportedly acquired a substantial stake in Catalent Inc (NYSE: CTLT). They are now advocating for a significant overhaul of the contract... 
Via Benzinga
Why Catalent Stock Flopped Today
The company takes the fall for a failed drug application. 
Via The Motley Fool
Top 5 Performing S&P 500 Stocks This Week: 2 Are AI Latecomers, 1 Was Nearly Sunk By Covid
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
Via Benzinga
Advanced Micro Devices To Rally Around 17%? Here Are 10 Other Analyst Forecasts For Wednesday
Raymond James cut the price target for W. P. Carey Inc. (NYSE: WPC) from $85 to $78. Raymond James analyst RJ Milligan maintained an Outperform rating. W. P. Carey shares fell 0.3% to $70.11 in... 
Via Benzinga
Catalent 'Is Starting To Move In The Right Direction,' Analyst Says, But Cautions Lack of Visibility for FY24
Monday, Catalent Inc (NYSE: CTLT) announced Q3 results that it  
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.